Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer
K. Kim, H. Kim, I. Shin…·J. K. Choi
This study develops iMethyl, a method to estimate genomic hypomethylation from cell-free DNA to predict responses to immune checkpoint blockade in cancer patients.